Literature DB >> 23944846

Synthesis and antitumor activity of tetrandrine derivatives.

Chun-Zhen Wu1, Long Lai, Xiao Hu, Rong-Rong Lei, Yi-Fang Yang.   

Abstract

Tetrandrine possesses antitumor activity, however, only a few studies on its structure modification were reported. To improve the antitumor activity of tetrandrine, 20 new tetrandrine derivatives were designed and synthesized by Sonogashira and Suzuki reactions. Their antitumor activities were evaluated against three tumor cell lines including A549, HepG2, and BGC-823 by methyl thiazolyl tetrazolium assay with taxol as a positive control. The results showed that compounds 2c and 2g were highly potent against BGC-823 cell line, and compounds 1i and 1k showed particular activity against HepG2 cells. These results demonstrated that compounds 1i, 1k, 2c, and 2g were promising leads for further investigation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23944846     DOI: 10.1080/10286020.2013.823950

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  3 in total

1.  Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.

Authors:  Junrong Song; Junjie Lan; Chao Chen; Shengcao Hu; Jialei Song; Wulin Liu; Xueyi Zeng; Huayong Lou; Yaacov Ben-David; Weidong Pan
Journal:  Medchemcomm       Date:  2018-05-04       Impact factor: 3.597

Review 2.  Progress on structural modification of Tetrandrine with wide range of pharmacological activities.

Authors:  Liuying Mo; Fan Zhang; Feng Chen; Lei Xia; Yi Huang; Yuemi Mo; Lingqiu Zhang; Daquan Huang; Shunli He; Jiagang Deng; Erwei Hao; Zhengcai Du
Journal:  Front Pharmacol       Date:  2022-08-16       Impact factor: 5.988

3.  Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.

Authors:  Sheng-Cao Hu; Jin Yang; Chao Chen; Jun-Rong Song; Wei-Dong Pan
Journal:  Molecules       Date:  2020-04-09       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.